Filing Flows › Jazz Pharmaceuticals (JAZZ) › Operating margin
Jazz Pharmaceuticals (JAZZ) operating margin by quarter
Jazz Pharmaceuticals' operating margin was 20.5% in Q2 2026 (second quarter 2026), -10.9 pts from Q1 2026. Over the last 4 quarters it ranged from 5.1% (Q3 2025) to 31.5% (Q1 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 20.5% | -10.9 pts | — |
| Q1 2026 | 31.5% | +10.2 pts | — |
| Q4 2025 | 21.2% | +16.1 pts | — |
| Q3 2025 | 5.1% | — | — |
Q2 2026 at a glance
Jazz Pharmaceuticals, Q2 2026: revenue $1.2B (+16% year over year), operating margin 20.5%, net earnings $193M, operating cash flow $416M. The chart follows the revenue to costs, profit and cash.
Questions
What is Jazz Pharmaceuticals' operating margin?
Jazz Pharmaceuticals' operating margin was 20.5% in Q2 2026 (second quarter 2026), -10.9 pts from Q1 2026.
How has Jazz Pharmaceuticals' operating margin changed?
Over the last 4 quarters it ranged from 5.1% (Q3 2025) to 31.5% (Q1 2026).